GrowBlox Sciences Inc. Secures Special Use Permit For Medical Marijuana


Follow this company

Companies Mentioned

OTC:BB:GBLX / PK:ATTBF / PK:FITX
06/10/2014 [ACCESSWIRE]

GrowBlox Sciences, Inc. (OTCQB: GBLX) saw its share volume continue to surge on June 9th with 1,503,052 shares exchanging hands, 12 times higher than its three month daily average volume of 123,219 shares.

GrowBLOX Sciences, Inc., a biotechnology and research company, announced last week through its local partnership, GB Sciences Nevada, LLC, that it has secured a special use permit in Clark County, Nevada for its medical marijuana establishment.  The Company completed its presentation to the Board of Commissioners and was successful in acquiring this special use permit for its Fort Apache dispensary.  The Company will await final State approval and will be applying for a State business license in the coming weeks.

GrowBLOX Sciences, CEO, Craig Ellins said, "The Company is extremely excited to move forward in its Nevada initiatives and we are pleased to have secured a special use permit from Clark County.  Clark County Commissioners conducted a thorough process in vetting all applications.  A lot of man-hours were put in and they did a wonderful job.  Our Fort Apache location will bring much needed relief to local patients and will have a positive impact on the community.  I am happy to say this is a good day for GrowBLOX, and a great day for patients and the State of Nevada."

GBLX closed the day at $1.66, 3.75% higher than its previous close of $1.60.

PennyPickAlerts.com is one of the most talked about stock newsletters in the world. To receive 100% FREE stock alerts that have incredible potential, sign up here:

http://www.pennypickalerts.com

 

Abbatis Bioceuticals Leases 16,200 Square Foot Facility Zoned For Medical Marijuana

Abbatis Bioceuticals Corp. (OTCPINK: ATTBF) saw its share volume rise on June 9th with 1,397,331 shares exchanging hands, slightly higher than its three month daily average volume of 989,574 shares.

Abbatis Bioceuticals, a vertically integrated biotechnology company focused on cultivating botanicals, licensing and marketing proprietary bio-similar compounds, and unique extraction technologies and consulting services to medicinal markets in North America, announced that it has leased a 16,200 square foot facility zoned for medical marijuana near Vancouver, B.C. with the potential to expand to up to 254,000 square feet.

"We are committed to achieving Licensed Producer status under Health Canada's MMPR," said Abattis Bioceuticals Corp. President and CEO Michael Withrow. "The new growing facility takes us closer to securing the license and positions us for long-term expansion with up to 254,000 square feet of growing space. Several of our subsidiaries are in the late stages of the MMPR licensing process and we continue an active dialogue with Health Canada as we work toward the approvals on the applications we have submitted."

ATTBF closed the day at $.485 on June 9th, 19.17% lower than its previous close of $.60.

PennyPickAlerts.com is one of the most talked about stock newsletters in the world. To receive 100% FREE stock alerts that have incredible potential, sign up here:

http://www.pennypickalerts.com

 

FITX Adds Dr. Sam Alawieh To Its Board of Directors

Creative Edge Nutrition, Inc. (OTCPINK: FITX) saw its share volume plummet on June 9th with 13,112,862 shares exchanging hands, three times lower than its three month daily average volume of 41,446,696 shares.

Creative Edge Nutrition announced the addition of Dr. Sam Alawieh to its Board of Directors yesterday. 

"Bill and I have had many conversations of identifying how to not only contribute back to Windsor & Essex County, but more importantly identify on a global platform the raw talent that exists right here in this city" states Dr. Sam Alawieh. Dr. Alawieh has been instrumental in acquiring and developing local and global talent for Creative Edge Nutrition Inc.

"We are proud to announce the addition of Dr. Sam Alawieh to our Board of Directors. Sam is much more than a great friend, father and who I consider a brother in this great journey as we implement and execute a shared vision of the building of our great company and an industry. Sam has been a valued asset to our company and its shareholders long before his name was ever mentioned publicly. A controversial speaker at times, the genius of Dr. Alawieh comes to light in his many areas of expertise, including but not limited to pharmaceutical compounding, pharmaceutical cGMP and workflow models, brand creation and development, business mergers and acquisitions," stated President & CEO Bill Chaaban.

FITX closed the day at $.0595 on June 9th.

PennyPickAlerts.com is one of the most talked about stock newsletters in the world. To receive 100% FREE stock alerts that have incredible potential, sign up here:

http://www.pennypickalerts.com

 

ABOUT US:

Pennypickalerts.com issues momentum alerts on stocks that can provide gains to day traders.

Pennypickalerts.com provides members with timely information and exclusive alerts on cheap and under-valued stocks in the United States with the potential to deliver gains of 100% - 200% or more.

Pennypickalerts.com monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities. Through a vast network of IR professionals Pennypickalerts.com is often in the know of several large investor awareness campaigns being deployed.

Timing is everything when trading Penny Stocks. Gain an Edge by joining the Pennypickalerts.com newsletter and receiving alerts from a Pro-Active team of researchers. Pennypickalerts.com believes traders should have a chance at successfully trading penny stocks and invites traders and investors to be part of the Free VIP membership.

Simply sign up for free and start receiving exclusive alerts.

Subscribe Here: http://www.pennypickalerts.com

 

Disclosure:

Pennypickalerts.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always own due diligence with any potential investment.

COMMENTS

Leave a comment...
 * 

Your Name
 *